Introduction: Traditional and current perception for benefit of percutaneous coronary
intervention (PCI) is that patients with stable angina will obtain symptom relief as well as …

Background Percutaneous coronary intervention (PCI) is commonly used to relieve
symptoms in chronic stable angina. However, there has no been no study of PCI against a …

Background Symptomatic relief is the primary goal of percutaneous coronary intervention
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …

The debate over coronary revascularization in stable ischemic heart disease has grown over
the past decade, sparked by the landmark COURAGE (Clinical Outcomes Utilizing …

Coronary artery disease is one of the leading causes of death in the United States. The utility
of revascularization in patients presenting with acute coronary syndrome is well elucidated …

Percutaneous coronary intervention (PCI) is frequently performed for stable angina.
However, the first blinded trial, ORBITA, did not show a placebo-controlled increment in …

Purpose of review Coronary artery disease remains the most common cause of death
worldwide. In patients with biomarker-positive acute coronary syndrome, the combination of …

Answer: The 2 ORBITA studies aim to settle the debate on the utility of coronary
revascularization in patients with stable chronic angina and coronary artery lesions causing …

The goal of treatment in stable coronary artery disease is to improve prognosis and quality of
life of the patients. International Guidelines support revascularization procedures for …

The release of the COURAGE trial results has fuelled the debate over the benefits of
percutaneous coronary interventions (PCI) in stable angina [1]. To date PCI, when compared …